Viewing stories from October, 2011
Appendix 4C - Quarterly Cashflow Report
Starpharma today released its Quarterly Cash Flow Report for the period ended 30 September 2011.
ABC Radio Australia – Innovations: VivaGel Phase 3 Trial Gets Go-Ahead from FDA
ABC Radio Innovations Host Desley Blanch interviews Starpharma CEO Dr Jackie Fairley about the significance of Starpharma receiving FDA approval for the commencement of a Phase III clinical trial testing VivaGel for the treatment of Bacterial Vaginosis.
Go to the article (external link)
Starpharma secures FDA agreement on BV treatment Phase 3
Starpharma today announced that the Phase 3 clinical trial program for the VivaGel® bacterial vaginosis (BV) treatment program has been agreed with the US FDA following recent positive trial results and subsequent End of Phase 2 Meeting.